Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Armin Ghobadi | Researchclopedia

Back to researchers

Armin Ghobadi

Saint Louis University ORCID

336

Works

21,713

Citations

46

h-index

104

i10-index

Research Topics

CAR-T cell therapy research Lymphoma Diagnosis and Treatment Acute Lymphoblastic Leukemia research

Affiliations

University of Maryland, Baltimore2021–2023

Barnes-Jewish Hospital2019–2022

City Of Hope National Medical Center2024–2024

St. Louis Children's Hospital2013–2019

Memorial Sloan Kettering Cancer Center2021–2021

Top Works

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

Sattva S. Neelapu,Frederick L. Locke,et al.

20175,749 citations

Chronic Lymphocytic Leukemia Research

Hematopoietic Stem Cell Transplantation

ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells

Daniel W. Lee,Bianca Santomasso,et al.

20183,235 citations

Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial

Frederick L. Locke,Armin Ghobadi,et al.

20182,189 citations

Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma

Frederick L. Locke,David B. Miklos,et al.

20211,435 citations

<i>TP53</i> and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes

John S. Welch,Allegra A. Petti,et al.

2016779 citations

Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium

Loretta J. Nastoupil,Michael D. Jain,et al.

2020763 citations

KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study

Bijal Shah,Armin Ghobadi,et al.

2021739 citations

Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma

Frederick L. Locke,Sattva S. Neelapu,et al.

2017607 citations

Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma

Frederick L. Locke,John M. Rossi,et al.

2020434 citations